<DOC>
	<DOCNO>NCT01921907</DOCNO>
	<brief_summary>A topical treatment apply twice daily 4 week induce disappearance facial actinic keratosis ( AK ) . First 4 week treatment ( visit 1 , 2 3 0,2 4 week ) treat double blind parallel study . From week 4 7 ( visit 3 visit 4 ) patient treat active component .</brief_summary>
	<brief_title>Evaluation Topical Treatment Actinic Keratosis</brief_title>
	<detailed_description />
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<criteria>Males females 30 90 year old , inclusive , good general health Clinical diagnosis Actinic Keratosis At least 2 clinically diagnose , 315 mm AK lesion face scalp Patient competent understand sign consent form , willing able follow study procedure attend visit Female patient childbearing potential must negative urine pregnancy test prior receive study medication Sexually active woman childbearing potential participating study must use medically acceptable form contraception Pharmacologic method contraception stable 1 month prior Visit 1 maintain dose study Patients treat : 5FU , diclofenac , retinoids , ingenol mebutate imiquimod within 4 week study , immunomodulators , interferon/interferon inducer systemic immunosuppressant within 8 week study , cryodestruction , curettage , photodynamic therapy , surgical excision treatment area within 4 week study , systemic cancer therapy , UVA therapy , UVB therapy , laser abrasion , dermabrasion History hereditary angioedema , Epilepsy Parkinson 's Disease Erythroderma history immunodeficiency disorder Pregnancy , lactation patient practice effective contraception History alcohol drug abuse within 5 year screen Known hypersensitivity previous allergic reaction component study medication Having member household trial Patient participate investigational clinical , surgical , drug device study within past 30 day Patients opinion investigator include study reason , include inability follow procedure</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Actinic keratosis</keyword>
	<keyword>topical</keyword>
	<keyword>dermatology</keyword>
	<keyword>treatment</keyword>
	<keyword>clinical study</keyword>
	<keyword>double blind</keyword>
</DOC>